Cargando…

Correction: DNA Methylation Analysis of the Macrosatellite Repeat Associated with FSHD Muscular Dystrophy at Single Nucleotide Level

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368830/ https://www.ncbi.nlm.nih.gov/pubmed/25793941 http://dx.doi.org/10.1371/journal.pone.0119742

Ejemplares similares

DNA Methylation Analysis of the Macrosatellite Repeat Associated with FSHD Muscular Dystrophy at Single Nucleotide Level
por: Huichalaf, Claudia, et al.
Publicado: (2014)

Intrinsic Epigenetic Regulation of the D4Z4 Macrosatellite Repeat in a Transgenic Mouse Model for FSHD
por: Krom, Yvonne D., et al.
Publicado: (2013)

Filling in the Gap of Human Chromosome 4: Single Molecule Real Time Sequencing of Macrosatellite Repeats in the Facioscapulohumeral Muscular Dystrophy Locus
por: Morioka, Masaki Suimye, et al.
Publicado: (2016)

Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Ducharme-Smith, Allison, et al.
Publicado: (2021)

FSHD: copy number variations on the theme of muscular dystrophy
por: Cabianca, Daphne Selvaggia, et al.
Publicado: (2010)

UK Facioscapulohumeral Muscular Dystrophy (FSHD) Patient Registry
por: Wood, Libby, et al.
Publicado: (2014)

Orofacial Muscle Weakening in Facioscapulohumeral Muscular Dystrophy (FSHD) Patients
por: Konstantonis, Dimitrios, et al.
Publicado: (2022)

DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy
por: Mocciaro, Emanuele, et al.
Publicado: (2021)

Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD): A Systematic Review
por: Aguirre, Alex S, et al.
Publicado: (2023)

Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD)
por: Dai, Yi, et al.
Publicado: (2020)

Direct interplay between two candidate genes in FSHD muscular dystrophy
por: Ferri, Giulia, et al.
Publicado: (2015)

Facioscapulohumeral muscular dystrophy (FSHD) and multiple sclerosis: a case report
por: Iodice, Rosa, et al.
Publicado: (2020)

MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy
por: Runfola, Valeria, et al.
Publicado: (2023)

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy
por: Jones, Takako I, et al.
Publicado: (2015)

The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS)
por: Mul, Karlien, et al.
Publicado: (2021)

Polycomb repressive complex 1 provides a molecular explanation for repeat copy number dependency in FSHD muscular dystrophy
por: Casa, Valentina, et al.
Publicado: (2017)

Does DNA Methylation Matter in FSHD?
por: Salsi, Valentina, et al.
Publicado: (2020)

Emerging roles of macrosatellite repeats in genome organization and disease development
por: Dumbovic, Gabrijela, et al.
Publicado: (2017)

Telomere Position Effect (TPE) Regulates DUX4 in Human Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Stadler, Guido, et al.
Publicado: (2013)

WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy
por: Mocciaro, Emanuele, et al.
Publicado: (2023)

FHL1 Reduces Dystrophy in Transgenic Mice Overexpressing FSHD Muscular Dystrophy Region Gene 1 (FRG1)
por: Feeney, Sandra J., et al.
Publicado: (2015)

Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation
por: Bodega, Beatrice, et al.
Publicado: (2009)

The FSHD muscle–blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy
por: Banerji, Christopher R S, et al.
Publicado: (2023)

Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping
por: Guruju, Naga M., et al.
Publicado: (2023)

Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Jones, Takako I., et al.
Publicado: (2016)

A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)
por: Petek, Lisa M., et al.
Publicado: (2016)

A case of type 1 facioscapulohumeral muscular dystrophy (FSHD) with restrictive ventilatory defect and congestive heart failure
por: Morimoto, Nobutoshi, et al.
Publicado: (2020)

The D4Z4 Macrosatellite Repeat Acts as a CTCF and A-Type Lamins-Dependent Insulator in Facio-Scapulo-Humeral Dystrophy
por: Ottaviani, Alexandre, et al.
Publicado: (2009)

Correction: 24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy
por: Mazzone, Elena Stacy, et al.
Publicado: (2013)

Correction: Expression profiling of disease progression in canine model of Duchenne muscular dystrophy
por: Brinkmeyer-Langford, Candice, et al.
Publicado: (2020)

Author Correction: Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model
por: Bosnakovski, Darko, et al.
Publicado: (2018)

Correction: DNA Dynamics Is Likely to Be a Factor in the Genomic Nucleotide Repeats Expansions Related to Diseases
por: Alexandrov, Boian S., et al.
Publicado: (2011)

Expression, tandem repeat copy number variation and stability of four macrosatellite arrays in the human genome
por: Tremblay, Deanna C, et al.
Publicado: (2010)

A Long ncRNA Links Copy Number Variation to a Polycomb/Trithorax Epigenetic Switch in FSHD Muscular Dystrophy
por: Cabianca, Daphne S., et al.
Publicado: (2012)

Rbfox1 Downregulation and Altered Calpain 3 Splicing by FRG1 in a Mouse Model of Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Pistoni, Mariaelena, et al.
Publicado: (2013)

Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)
por: Ansseau, Eugénie, et al.
Publicado: (2017)

Correction: dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy
por: Mehuron, Thomas, et al.
Publicado: (2014)

Author Correction: Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy
por: Murakami, Terumi, et al.
Publicado: (2022)

Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
por: Boca, Simina M., et al.
Publicado: (2016)

Correction: Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7r13a4h3mjdrrjpqb9q4ivha53